Skip to main content
Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: Unraveling heterogeneity within ACPA-negative rheumatoid arthritis: the subgroup of patients with a strong clinical and serological response to initiation of DMARD treatment favor disease resolution

Fig. 3

In APCA-negative RA, high baseline levels of MMP-3, SAA, and CRP are related to a strong decline in these levels after DMARD start.

Correlation between baseline levels and change in the levels between baseline and 12 months, separately for the SDFR and non-SDFR group. ρ reflects Spearman’s rho. CRP, C-reactive protein; MMP, matrix metalloproteinase; SAA, serum A amyloid; SDFR, sustained DMARD-free remission

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us